Literature DB >> 1542548

Growth in cartilage-hair hypoplasia.

O Mäkitie1, J Perheentupa, I Kaitila.   

Abstract

Cartilage-hair hypoplasia is an osteochondrodysplasia with short-limbed short stature. The cartilage-hair hypoplasia gene is exceptionally prevalent in Finland; more than 100 patients have been identified. We have analyzed the growth of 100 Finnish patients and present cartilage-hair hypoplasia-specific growth charts of height and weight for height. The disproportions were analyzed by sitting height, subischial leg height, sitting height:height ratio, and span-height difference. The stature was short at birth with a mean relative length of -3.0 SD. The median adult height was 131.1 cm (-7.9 SD, range 110.7 to 149.0 cm) for 15 males and 122.5 cm (-7.9 SD, range 103.7 to 137.4 cm) for 20 females. The progression of the growth failure was partly explained by weakness or absence of pubertal growth spurt. Weight for height was above normal median in childhood and increased further at puberty. Most of the adults were overweight. The adults' mean relative head circumference was -0.9 SD. Growth was disturbed both in the limbs and in the spine, more severely in the limbs. Adult height showed no correlation with the midparent height. The charts are useful for assessment of growth, prediction of adult height, detection of superimposed disorders, and evaluation of growth-accelerating therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1542548     DOI: 10.1203/00006450-199202000-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients.

Authors:  O Mäkitie
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Cartilage-hair hypoplasia syndrome: increased apoptosis of T lymphocytes is associated with altered expression of Fas (CD95), FasL (CD95L), IAP, Bax, and Bcl2.

Authors:  L Yel; S Aggarwal; S Gupta
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia.

Authors:  F Berthet; C A Siegrist; H Ozsahin; P Tuchschmid; G Eich; A Superti-Furga; R A Seger
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 4.  Cartilage-hair hypoplasia.

Authors:  O Mäkitie; T Sulisalo; A de la Chapelle; I Kaitila
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

5.  An infant with cartilage-hair hypoplasia due to a novel homozygous mutation in the promoter region of the RMRP gene associated with chondrodysplasia and severe immunodeficiency.

Authors:  N Vatanavicharn; N Visitsunthorn; T Pho-iam; O Jirapongsananuruk; P Pacharn; K Chokephaibulkit; C Limwongse; P Wasant
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 6.  Clinical and imaging considerations in primary immunodeficiency disorders: an update.

Authors:  Eveline Y Wu; Lauren Ehrlich; Brian Handly; Donald P Frush; Rebecca H Buckley
Journal:  Pediatr Radiol       Date:  2016-09-22

7.  Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients.

Authors:  O Mäkitie; E Marttinen; I Kaitila
Journal:  Pediatr Radiol       Date:  1992

8.  Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients.

Authors:  O Mäkitie; I Kaitila
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

9.  Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.

Authors:  Patrick Riley; Dennis S Weiner; Bonnie Leighley; David Jonah; D Holmes Morton; Kevin A Strauss; Michael B Bober; Martin S Dicintio
Journal:  J Child Orthop       Date:  2015-03-13       Impact factor: 1.548

10.  Pulmonary Follow-Up Imaging in Cartilage-Hair Hypoplasia: a Prospective Cohort Study.

Authors:  Svetlana Vakkilainen; Paula Klemetti; Timi Martelius; Mikko Jr Seppänen; Outi Mäkitie; Sanna Toiviainen-Salo
Journal:  J Clin Immunol       Date:  2021-03-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.